FindTrial
Sign In

Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in Leipzig

Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in Leipzig

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023364
Enrollment
2000
Registered
2020-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: No intervention. Examination of the SARS CoV-2-specific antibody response in left-over serum and blood samples

Sponsors

Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Four groups of individuals: 1. All patients at the University Hospital from which blood has been taken for medical reasons 2. Blood donors 3. Patients from the neurologic walk-in clinic 4. Patients with advanced liver disease

Exclusion criteria

Exclusion criteria: Serum and plasma samples that are not suitable for technical reasons

Design outcomes

Primary

MeasureTime frame
IgG antibody response to SARS CoV-2 will be tested using an antibody test (e. g. ELISA)—

Secondary

MeasureTime frame
No other measurements—

Countries

Germany

Contacts

Public ContactChristian Jassoy

Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig

christian.jassoy@medizin.uni-leipzig.de0341 9714314

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026